VENI.CN Stock Trades at C$0.005 on April 20, 2026

Vencanna Ventures Inc. (VENI.CN) trades at C$0.005 on the CNQ exchange as of April 20, 2026. The cannabis venture capital company shows mixed signals for investors. VENI.CN stock has declined significantly over the past decade, down 98.67% from its 10-year high. The company focuses on providing capital for early-stage global cannabis initiatives from its Calgary headquarters. With 222.6 million shares outstanding and a market cap of C$1.11 million, VENI.CN stock remains thinly traded. Today’s volume reached 62,000 shares, well above the 4,338-share average.

VENI.CN Stock Price and Technical Setup

VENI.CN stock trades at C$0.005 with no price movement today. The stock has held steady at this level for weeks, showing minimal volatility. Year-to-date performance data is unavailable, but the 52-week range spans C$0.005 to C$0.015. The 50-day moving average sits at C$0.005, while the 200-day average is C$0.006825. This suggests VENI.CN stock trades below its longer-term trend. Technical indicators show neutral readings with RSI at zero and MACD flat. The stock’s tight trading range reflects low liquidity and limited investor interest in the cannabis venture sector.

Meyka AI Grade and Fundamental Analysis

Meyka AI rates VENI.CN with a grade of B-, suggesting a Hold recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating score of 2 out of 10 reflects significant concerns. DCF analysis shows strong buy signals, but profitability metrics are deeply negative. Return on equity stands at -87.46%, while return on assets is -95.20%. The company’s price-to-book ratio of 0.34 indicates the stock trades well below book value. These grades are not guaranteed and we are not financial advisors.

Financial Health and Cash Position

Vencanna Ventures faces serious financial challenges. The company reported negative earnings per share of -C$0.01 with a negative PE ratio of -0.5. Operating cash flow per share is -C$0.0018, while free cash flow per share is -C$0.0026. The current ratio of 0.38 indicates liquidity stress, as current liabilities exceed current assets. Working capital stands at negative C$988,172. Revenue per share is only C$0.0115, generating minimal income. The company carries debt-to-equity of 0.19 and debt-to-assets of 0.17. Interest coverage is deeply negative at -6.36, showing the company cannot service debt from operations.

Market Sentiment and Trading Activity

Trading Activity: VENI.CN stock volume surged to 62,000 shares today, representing 14.29x the average daily volume of 4,338 shares. This spike suggests renewed interest despite the stock’s weak fundamentals. The relative volume increase indicates traders are testing support at C$0.005. Liquidation: No significant liquidation pressure appears evident at current levels. The stock’s minimal market cap of C$1.11 million means even modest trading moves the price. Institutional ownership data is unavailable, limiting visibility into large holder activity. The thin float and low liquidity create both opportunity and risk for oversold bounce traders.

Cannabis Sector Context and Industry Headwinds

Vencanna Ventures operates in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector. The broader cannabis industry faces regulatory uncertainty and market saturation. The company’s business model of providing capital to early-stage cannabis initiatives has proven challenging. Revenue declined 60% year-over-year, while gross profit fell 81.94%. The company has not achieved profitability and shows no clear path to positive earnings. Track VENI.CN on Meyka for real-time updates on this cannabis venture play. Sector headwinds continue to pressure smaller players like Vencanna.

Valuation and Long-Term Decline

VENI.CN stock has experienced catastrophic long-term losses. The stock is down 91.67% over three years, 90.91% over five years, and 98.67% over ten years. The all-time decline from peak is 99.2%, indicating severe shareholder destruction. Enterprise value stands at C$1.25 million against minimal revenue generation. The price-to-sales ratio of 0.32 appears cheap but reflects the company’s inability to generate profits. Book value per share is C$0.0030, suggesting limited tangible asset backing. The stock’s extreme decline reflects fundamental business deterioration rather than temporary market weakness.

Final Thoughts

VENI.CN stock trades at C$0.005 on the CNQ exchange with mixed signals for investors. Meyka AI’s B- grade and Sell recommendation reflect deep profitability concerns and negative cash flows. The company’s cannabis venture capital model has failed to generate sustainable returns. Revenue collapsed 60% year-over-year while losses widened. The stock’s 99.2% all-time decline shows this is not a typical oversold bounce opportunity. Current valuations appear cheap only because the business is broken. Investors should recognize that VENI.CN stock faces existential challenges beyond temporary market weakness. The company needs fundamental operational turnaround, not just price recovery. Without clear strategic direction and path to profitability, this remains a high-risk speculative position. Cautious investors should wait for evidence of business stabilization before considering entry.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.